CorMedix Inc. (CRMD) Financials Nov 14, 2014, 3:58 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for CorMedix Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 2,001
Cost of Goods Sold (COGS) incl. D&A 163,587 370,662 12,246 7,022 206,766
COGS excluding D&A 0 0 0 0 201,605
Depreciation & Amortization Expense 163,587 370,662 12,246 7,022 5,161
Depreciation 9,945 12,167 12,246 7,022 5,161
Amortization of Intangibles 0 0 0 0 0
Gross Income (163,587) (370,662) (12,246) (7,022) (204,765)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.89M 8.14M 7.23M 3.04M 4.71M
Research & Development 4.89M 5.49M 4.1M 1.19M 1.23M
Other SG&A 1M 2.64M 3.14M 1.85M 3.48M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 2.77M
EBIT after Unusual Expense 0 0 0 0 (2.77M)
Non Operating Income/Expense 0 391,168 29,819 0 (4,513)
Non-Operating Interest Income 2,130 23,442 12,037 1,965 668
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 2.07M 3.09M 0 382,936 1.44M
Gross Interest Expense 2.07M 3.09M 0 382,936 1.44M
Interest Capitalized 0 0 0 0 0
Pretax Income (8.12M) (11.19M) (7.21M) (3.43M) (9.13M)
Income Tax 0 (280,920) (493,855) 0 0
Income Tax - Current Domestic - - (493,855) 0 0
Income Tax - Current Foreign - - 0 - -
Income Tax - Deferred Domestic - - 0 0 0
Income Tax - Deferred Foreign - - 0 - -
Income Tax Credits - - 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (8.12M) (10.91M) (6.71M) (3.43M) (9.13M)
Minority Interest Expense 0 0 0 0 0
Net Income (8.12M) (10.91M) (6.71M) (3.43M) (9.13M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (8.12M) (10.91M) (6.71M) (3.43M) (9.13M)
Preferred Dividends 0 0 0 0 384,307
Net Income Available to Common (8.12M) (10.91M) (6.71M) (3.43M) (9.52M)
EPS (Basic) (0.71) (1.15) (0.59) (0.30) (0.69)
Basic Shares Outstanding 11.41M 9.47M 11.41M 11.41M 13.82M
EPS (Diluted) (0.71) (1.15) (0.59) (0.30) (0.69)
Diluted Shares Outstanding 11.41M 9.47M 11.41M 11.41M 13.82M
EBITDA (5.89M) (8.14M) (7.23M) (3.04M) (4.91M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for CorMedix Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 2,001
Cost of Goods Sold (COGS) incl. D&A 163,587 370,662 12,246 7,022 206,766
COGS excluding D&A 0 0 0 0 201,605
Depreciation & Amortization Expense 163,587 370,662 12,246 7,022 5,161
Depreciation 9,945 12,167 12,246 7,022 5,161
Amortization of Intangibles 0 0 0 0 0
Gross Income (163,587) (370,662) (12,246) (7,022) (204,765)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.89M 8.14M 7.23M 3.04M 4.71M
Research & Development 4.89M 5.49M 4.1M 1.19M 1.23M
Other SG&A 1M 2.64M 3.14M 1.85M 3.48M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 2.77M
EBIT after Unusual Expense 0 0 0 0 (2.77M)
Non Operating Income/Expense 0 391,168 29,819 0 (4,513)
Non-Operating Interest Income 2,130 23,442 12,037 1,965 668
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 2.07M 3.09M 0 382,936 1.44M
Gross Interest Expense 2.07M 3.09M 0 382,936 1.44M
Interest Capitalized 0 0 0 0 0
Pretax Income (8.12M) (11.19M) (7.21M) (3.43M) (9.13M)
Income Tax 0 (280,920) (493,855) 0 0
Income Tax - Current Domestic - - (493,855) 0 0
Income Tax - Current Foreign - - 0 - -
Income Tax - Deferred Domestic - - 0 0 0
Income Tax - Deferred Foreign - - 0 - -
Income Tax Credits - - 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (8.12M) (10.91M) (6.71M) (3.43M) (9.13M)
Minority Interest Expense 0 0 0 0 0
Net Income (8.12M) (10.91M) (6.71M) (3.43M) (9.13M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (8.12M) (10.91M) (6.71M) (3.43M) (9.13M)
Preferred Dividends 0 0 0 0 384,307
Net Income Available to Common (8.12M) (10.91M) (6.71M) (3.43M) (9.52M)
EPS (Basic) (0.71) (1.15) (0.59) (0.30) (0.69)
Basic Shares Outstanding 11.41M 9.47M 11.41M 11.41M 13.82M
EPS (Diluted) (0.71) (1.15) (0.59) (0.30) (0.69)
Diluted Shares Outstanding 11.41M 9.47M 11.41M 11.41M 13.82M
EBITDA (5.89M) (8.14M) (7.23M) (3.04M) (4.91M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
